Patients with cancer who received prophylactic intravenous (IV) magnesium before starting cisplatin had a lower risk for cisplatin-associated acute kidney injury (AKI) than those who did not ...

Cisplatin, a crucial chemotherapy drug, has been in short supply since February. NBC News mapped the drug’s journey across the globe to show how the shortage came to be. By Berkeley Lovelace Jr ...

Cisplatin and other platinum-based drugs are prescribed for 10% to 20% of all cancer patients, according to the National Cancer Institute. Cisplatin has a cure rate of over 90% when used to treat ...